Most of what I write about regulation on this site is genuinely uncertain — what the FDA will do with the 503A bulks list, when a proposed rule appears, which peptides survive notice-and-comment. Reasonable people disagree, and I try to say so.
This piece is not that. This one is settled law, and it is unusually easy for a patient to check.
In 2026 the Georgia Composite Medical Board began conducting unannounced site inspections of med spas, IV hydration clinics, and wellness practices across the state — rural and urban both. Reporting on what inspectors found describes medical services delivered by unlicensed workers, medications compounded unlawfully, staff practicing outside their training, clinics administering treatment without the required medical examination, and operators failing to track adverse events. It also describes something more specific: chiropractors offering popular weight-loss and testosterone treatments, in a state that does not allow chiropractors to prescribe medications or administer injections.
I want to be careful about the tone here. This is not a swipe at chiropractic. I refer patients to chiropractors, I think manual therapy is underrated for the right presentation, and a good one is worth finding. The issue is not the profession. The issue is that a license defines a boundary, and testosterone sits on the other side of that particular one.
What Georgia's chiropractic statute actually says.
Georgia defines chiropractic scope of practice at O.C.G.A. § 43-9-16. In substance, it describes chiropractic as the adjustment and manipulation of the articulations of the human body, together with related therapeutic procedures — therapeutic exercise, therapeutic activities, manual therapy techniques, massage, and structural supports as they relate to those articulations.
The statute permits chiropractors to recommend nutritional and dietary supplements. And then it does something that matters enormously for the current moment: it expressly provides that this recommendation authority may not be construed to allow treating patients outside the scope of chiropractic practice. The legislature anticipated the exact move — supplement authority being stretched into something broader — and closed it in the same breath.
Prescribing a Schedule III controlled substance is not manual therapy. Drawing testosterone cypionate into a syringe and putting it into a patient's gluteal muscle is not a structural support. Neither is a semaglutide or tirzepatide injection. There is no reading of § 43-9-16 that reaches them, which is why the Board's inspectors flagged it.
The license-by-license answer.
Here is the practical version. This is a general description of Georgia's framework as I understand it as a practicing physician — it is not legal advice, and any specific arrangement should be reviewed by health-care counsel.
| License type | May prescribe testosterone? | What the boundary looks like in practice |
|---|---|---|
| Physician — MD or DO | Yes — independently | Licensed by the Georgia Composite Medical Board. Independent prescriptive authority. Must also hold a valid DEA registration, because testosterone is a Schedule III controlled substance. This is the license that can also serve as the delegating or supervising physician for others. |
| Advanced Practice Registered Nurse (APRN / NP) | Yes — delegated | Requires an active nurse protocol agreement with a delegating physician. The authority is derivative: it exists because a specific physician delegated it, within defined parameters, and it is only as sound as that relationship. Controlled substances carry their own additional requirements. |
| Physician Assistant (PA) | Yes — delegated | Requires a board-approved job description with a supervising physician. Same structure as above: delegated, bounded, and dependent on a real supervisory relationship rather than a signed page in a drawer. |
| Registered Nurse / LPN | No | An RN may administer a medication pursuant to a valid order from a prescriber. An RN may not write that order. The Board's 2026 IV therapy position statement goes further and holds that a nurse cannot be the sole clinician interacting with the patient — a model built on that risks unauthorized-practice-of-medicine exposure. |
| Chiropractor (DC) | No | O.C.G.A. § 43-9-16 does not authorize prescribing or injecting. Supplement recommendation authority is expressly limited so that it cannot be stretched to cover treatment outside chiropractic scope. This is the category state inspectors flagged in 2026. |
| Esthetician / medical assistant / "wellness coach" | No | No prescriptive authority of any kind. Depending on the task and the delegation, administering injections may also fall outside what these roles may lawfully do. "Certified" in something is not the same as licensed to do it. |
The second question: not just who prescribed, but who is actually running the clinic.
Holding the right license is necessary and not sufficient. On May 7, 2026 the Georgia Composite Medical Board issued a position statement on IV hydration and IV therapy that reframes the whole category. Its core holdings, as I read them:
- IV therapy is the practice of medicine. Not a retail wellness service that happens to involve a needle.
- Generic standing orders are prohibited. Every infusion requires a valid individualized order.
- A prescriber must complete a history and physical before anything is mixed or administered. Not after. Not on the way out.
- A nurse cannot be the only clinician who interacts with the patient. This is the holding that ends the menu-based drip-bar model as a lawful structure in Georgia.
- A physician may not be financially dependent on the APRN they delegate to. The Board reads this broadly — beyond W-2 or 1099 status, to any compensation flowing from an APRN or APRN-owned entity to the delegating physician. Third-party medical-director matching services are named specifically.
- Substance over form. The Board evaluates the practical reality of the relationship, not the contract, the title, or the corporate structure. A signed agreement does not cure a non-compliant arrangement.
- The supervising physician's identity must be posted where the public has unrestricted access — practice, website, social.
- Compliance with Georgia pharmacy law and USP <797> where applicable.
Read those together and a pattern emerges. The Board is not primarily worried about which molecule is in the bag. It is worried about whether a physician is genuinely, practically, financially independent enough to say no — and whether anyone with the training to say no is in the building at all.
Two questions, before anyone injects you
- "Who signed my order, what is their license type, and are they here today?" You are entitled to a plain answer with a name. A physician, APRN, or PA should be identifiable. If the answer is a shrug, a first name, or "our medical director" with no name attached, that is the answer.
- "Did a prescriber examine me before this was prepared?" In Georgia, for IV therapy, the H&P comes first. If the exam is a two-minute form you filled in on a tablet in the waiting room and no prescriber ever laid eyes on you, the order underneath your infusion may not be what the Board considers valid.
Then verify. The Georgia Composite Medical Board publishes a public licensee lookup. The name you were given should appear there, with the license type you were told, in good standing. It takes about ninety seconds.
Why this matters more than the FDA story right now.
I've spent months on this site tracking the federal peptide question — the July advisory committee vote, the bulks list, what is and is not lawfully compoundable. That work matters, and I stand behind it. But the federal path runs on a 12-to-24-month rulemaking clock and lands on categories of substances.
The state path runs on a clock measured in weeks and lands on people. A board can act against a named licensee. Inspectors are, as of this summer, physically walking through the door in Georgia unannounced. The Board has said it intends to continue inspecting, to put the industry on notice regarding existing licensure and scope requirements, and to seek legislation imposing registration requirements on med spas and IV facilities. For a patient choosing where to go this year, the scope-of-practice question is simply the sharper screen — and unlike the FDA question, it has a definite answer you can look up yourself.
Where Limitless stands.
I will state our position plainly, because the Board's disclosure requirement is one I think every clinic should welcome rather than tolerate.
Joshua Hare, DO is the founder, owner, and supervising physician of Limitless Performance Medicine. I am licensed in Georgia and Tennessee, I hold the DEA registration under which controlled substances are prescribed here, and I perform the histories and physicals myself. Every order is individualized, written and signed for a named patient with the indication and dosing rationale documented in the chart. There is no standing order. There is no rented medical director, no third-party matching service, and no arrangement in which my compensation flows from a mid-level provider — because Limitless is physician-owned, which makes the question moot by construction rather than by contract.
None of that is a marketing achievement. It is the baseline. What has changed in 2026 is that Georgia turned the baseline into an enforcement priority — and a fair number of clinics in this market are going to discover the difference between a compliance page and a compliant practice with an inspector standing in the lobby.
If you are weighing clinics in North Georgia or the Tennessee Valley, the related reading is the field guide to choosing a peptide clinic and why state boards move faster than the FDA. And if you are considering IV therapy specifically, our NAD+ page now sets out the Board's requirements line by line, with how we meet each one.